QR-010
Showing 126 - 148 of 148
Atrial Fibrillation Trial (vernakalant HCl, Placebo to vernakalent HCl)
Completed
- Atrial Fibrillation
- vernakalant hydrochloride
- Placebo to vernakalent hydrochloride
- (no location specified)
Nov 9, 2015
Rotavirus Disease Trial (Rotavirus Vaccine, Live, Oral, Pentavalent, Comparator: , Comparator: Infanrix(tm) Hexa)
Completed
- Rotavirus Disease
- Rotavirus Vaccine, Live, Oral, Pentavalent
- +2 more
- (no location specified)
Oct 5, 2015
GVHD, Leukemia, MDS Trial in Los Angeles (biological, drug, procedure, radiation)
Withdrawn
- Graft Versus Host Disease
- +2 more
- autologous expanded mesenchymal stem cells OTI-010
- +6 more
-
Los Angeles, CaliforniaJonsson Comprehensive Cancer Center, UCLA
Dec 3, 2014
Alzheimer's Disease, Frontotemporal Dementia Trial in Manchester (florbetapir 18F, 18F-FDG)
Completed
- Alzheimer's Disease
- Frontotemporal Dementia
- florbetapir 18F
- 18F-FDG
-
Manchester, United KingdomResearch Site
Sep 16, 2014
Prostate Cancer, Tumor Metastasis Trial in United States (MDX-010)
Completed
- Prostate Cancer
- Neoplasm Metastasis
-
Los Angeles, California
- +13 more
Aug 14, 2014
Breast Cancer Trial in Worldwide (Tecemotide (L-BLP25) and Hormonal Treatment, Placebo of tecemotide (L-BLP25) and Hormonal
Terminated
- Breast Cancer
- Tecemotide (L-BLP25) and Hormonal Treatment
- +3 more
-
Hickory, North Carolina
- +28 more
Jul 23, 2014
Pectus Excavatum, Pain, Postoperative Trial in Jacksonville (Ultrasound-guided Sub-Paraspinal Block, PCA only)
Completed
- Pectus Excavatum
- Pain, Postoperative
- Ultrasound-guided Sub-Paraspinal Block
- PCA only
-
Jacksonville, FloridaWolfson Children's Hospital, Baptist Medical Center Downtown
Jun 20, 2014
Irritable Bowel Syndrome Constipation Predominant Trial in Rochester (ROSE-010, Placebo)
Completed
- Irritable Bowel Syndrome Constipation Predominant
- ROSE-010
- Placebo
-
Rochester, MinnesotaMayo Clinic Rochester
Apr 24, 2013
Intraocular Melanoma, Melanoma (Skin) Trial run by the NCI (aldesleukin, ipilimumab)
Completed
- Intraocular Melanoma
- Melanoma (Skin)
- aldesleukin
- ipilimumab
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 18, 2013
Multiple Myeloma Trial in Melbourne (Lenalidomide, dexamethasone, aspirin)
Unknown status
- Multiple Myeloma
- Lenalidomide
- +2 more
-
Melbourne, Victoria, AustraliaPeter MacCallum Cancer Centre
Jan 8, 2013
Melanoma (Skin) Trial run by the CC (gp100 antigen, incomplete Freund's adjuvant, ipilimumab)
Completed
- Melanoma (Skin)
- gp100 antigen
- +2 more
-
Bethesda, MarylandWarren Grant Magnuson Clinical Center - NCI Clinical Studies Sup
Jun 21, 2012
COPD Trial in New Braunfels, San Antonio (MN-221, Placebo)
Completed
- Chronic Obstructive Pulmonary Disease
- MN-221
- Placebo
-
New Braunfels, Texas
- +1 more
May 17, 2012
Prostate Cancer Trial in United States (MDX-010 / MDX-010 + Docetaxel)
Completed
- Prostate Cancer
- MDX-010 / MDX-010 + Docetaxel
-
Tucson, Arizona
- +10 more
Jun 23, 2011
Melanoma, Metastases Trial in Worldwide (MDX-010 (anti-CTLA4) mAb, MDX-1379 (gp100) Melanoma Peptide Vaccine)
Completed
- Melanoma
- Metastases
- MDX-010 (anti-CTLA4) monoclonal antibody
- MDX-1379 (gp100) Melanoma Peptide Vaccine
-
Tucson, Arizona
- +208 more
Jun 29, 2011
Melanoma Trial in United States (MDX-010 (CTLA-4))
Completed
- Melanoma
- MDX-010 (CTLA-4)
-
Tucson, Arizona
- +8 more
Jan 20, 2011
Long-term Data Collection for Subjects in MDX-010 Studies
Completed
- Metastatic Melanoma
-
Tuscon, Arizona
- +10 more
Apr 23, 2010
Malignant Melanoma Trial in United States (MDX-010)
Completed
- Malignant Melanoma
- MDX-010
-
Tucson, Arizona
- +3 more
Apr 23, 2010
Melanoma Trial in Worldwide (ipilimumab (MDX-010, BMS-734016), Ipilimumab)
Completed
- Melanoma
- ipilimumab (MDX-010, BMS-734016)
- Ipilimumab
-
Tucson, Arizona
- +61 more
Feb 27, 2010